Design and Structure-Activity Relationships of C-Terminal Cyclic Neurotensin Fragment Analogs

• Published in: Journal of medicinal chemistry 1995-01, Vol.38 (2), p.249-257
• Main Authors: Sefler, Andrea M, He, John X, Sawyer, Tomi K, Holub, Katherine E, Omecinsky, Diana O, Reily, Michael D, Thanabal, Venkataraman, Akunne, Hyacinth C, Cody, Wayne L
• Format: Article
• Language: English
• Subjects: Amino Acid Sequence; Biological and medical sciences; Calcium - metabolism; Cells, Cultured; Magnetic Resonance Spectroscopy; Medical sciences; Molecular Sequence Data; Neuropharmacology; Neurotensin - analogs & derivatives; Neurotensin - chemistry; Neurotensin - metabolism; Neurotransmitters. Neurotransmission. Receptors; Peptide Fragments - chemistry; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems; Peptides, Cyclic - chemistry; Pharmacology. Drug treatments; Receptors, Neurotensin - metabolism; Structure-Activity Relationship
• ISSN: 0022-2623; 1520-4804
• DOI: 10.1021/jm00002a006

Neurotensin (NT) is a linear tridecapeptide with a broad range of central and peripheral pharmacological effects. The C-terminal hexapeptide of NT (NT8-13) has been shown to possess similar properties to NT itself, and in fact, an analogue of NT8-13 (N alpha MeArg8-Lys-Pro-Trp-Tle-Leu13, Tle = tert-leucine) has been reported to possess central activity after peripheral administration. Cyclic derivatives of this hexapeptide were synthesized by a combination of solution and solid-phase peptide synthetic methodologies, and several analogues had low nanomolar binding affinity for the NT receptor. In particular, cyclo[Arg-Lys-Pro-Trp-Glu]-Leu (cyclized between the alpha amine of Arg and the gamma carboxylate of Glu) possessed 16 nM NT receptor affinity and was determined to be an agonist in vitro. 1H-NMR and 13C-edited 1H-NMR spectroscopy were performed on this and related cyclic analogues to help identify structural properties which may be important for receptor recognition. These cyclic peptides represent novel molecular probes to further investigate NT receptor pharmacology, as well as to advance our understanding of the structure-conformation relationships of NT and to help establish a working basis for additional pharmacophore mapping studies.